Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Randomized multicenter noninferiority phase III clinical trial of the first biosimilar of eculizumab.

Autor: Kulagin AD; RM Gorbacheva Research Institute, Pavlov University, 6/8 L'va Tolstogo St, Saint Petersburg, 197022, Russia. kulagingem@rambler.ru., Ptushkin VV; Botkin Moscow City Clinical Hospital, Moscow, Russia., Lukina EA; National Medical Research Center for Hematology, Moscow, Russia., Davydkin IL; Samara State Medical University, Samara, Russia., Korobkin AV; Chelyabinsk Regional Clinical Hospital, Chelyabinsk, Russia., Shamrai VS; Rostov Regional Clinical Hospital, Rostov-on-Don, Russia., Konstantinova TS; Sverdlovsk Regional Clinical Hospital No. 1, Yekaterinburg, Russia., Kaporskaya TS; Irkutsk Regional Clinical Hospital, Irkutsk, Russia., Mitina TA; Moscow Regional Clinical Research Institute Named After M.F. Vladimirsky, Moscow, Russia., Ksenzova TI; Tyumen Regional Clinical Hospital No. 1, Tyumen, Russia., Zuev EV; JSC GENERIUM, Volginsky Settlement, Vladimir Region, Russia., Markova OA; JSC GENERIUM, Volginsky Settlement, Vladimir Region, Russia., Gapchenko EV; JSC GENERIUM, Volginsky Settlement, Vladimir Region, Russia., Kudlay DA; JSC GENERIUM, Volginsky Settlement, Vladimir Region, Russia.; I.M. Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia.

Publikováno v: Annals of hematology [Ann Hematol] 2021 Nov; Vol. 100 (11), pp. 2689-2698. Date of Electronic Publication: 2021 Aug 16.